Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05266066 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation

Study acronym: VATICAN
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Site details revised at 16 of 16 sites
    v6
  2. Publications: 1 to 2v5
  3. Primary completion date: Nov 1, 2023 to Nov 1, 2026
    • Study completion date: Dec 1, 2023 to Dec 1, 2026
    v4
  4. Secondary endpoints: 7 to 8v3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2022 to Jul 11, 2022
    • Site details revised at 16 of 16 sites
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Ventilator Associated tracheobronchitis Initiative to Conduct Antibiotic evaluation (VATICAN) trial is a national, multicenter, non-inferiority trial in ICU patients comparing antibiotic treatment for 7 days versus clinical observation without antibiotic treatment for patients with ventilator-associated tracheobronchitis.
Trial Details
NCT Number NCT05266066
Lead Sponsor Hospital Sirio-Libanes
Collaborators: Hospital Israelita Albert Einstein, Hospital do Coracao, Hospital Moinhos de Vento, Hospital Alemão Oswaldo Cruz, BP - A Beneficência Portuguesa de São Paulo, Brazilian Research In Intensive Care Network
Conditions
(from sponsor)		 Ventilator Associated Tracheobronchitis, Tracheobronchitis
Related terms Critical Illness
Enrollment 590 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov